Available Forms: Tablets
Available Strengths: 2.5 mg
Reference Brands: Frova (USA/EU), Migard (USA/EU)
Category: Neurology
Frovatriptan is a selective serotonin (5-HT1) receptor agonist used to treat acute migraine attacks with or without aura. It works by narrowing blood vessels in the brain and reducing substances that trigger headache, nausea, and sensitivity to light and sound during a migraine episode. Frovatriptan succinate is available in Tablets and strengths such as 2.5 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Frovatriptan succinate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Frovatriptan succinate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Quick Response Guaranteed | Verified Suppliers
Frovatriptan succinate is used for the acute treatment of migraine headaches with or without aura in adults.
Frovatriptan succinate is made from the active ingredient Frovatriptan, a selective serotonin receptor agonist, combined with succinic acid to form the succinate salt.
The trade name of Frovatriptan succinate is Frova.
Frovatriptan succinate is manufactured by Endo Pharmaceuticals and originally developed by Vernalis.
The generic name is Frovatriptan succinate.
The brand name is Frova.
Frovatriptan succinate is manufactured in the United States, the United Kingdom, and India by various pharmaceutical companies for global distribution.
Strength: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
Strength: 50 mg, 100 mg
Form: Tablets
Reference Brands: Ubrelvy (USA/India)
Strength: 100 mg
Reference Brands: Tasmar (USA/EU)
Strength: 50 mg ,100 mg
Reference Brands: Xadago (USA/EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under ‘Fair use.’
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.